NEW YORK (AP) — Jury selection at the securities fraud trial of a former pharmaceutical CEO notorious for price-gouging has hit a rough patch….
NEW YORK (AP) — Jury selection at the securities fraud trial of a former pharmaceutical CEO notorious for price-gouging has hit a rough patch….